US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
RSS Feeds

Biotechnology market research reports and industry analysis

1  2  3    5    7  8  9  10  
Intercell AG : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Intercell AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Atrium Innovations, Inc. (formerly Atrium Biotechnologies, Inc.) : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Atrium Innovations, Inc. (formerly Atrium Biotechnologies, Inc.) Mergers & Acquisitions (M&A), Partnerships & Alliances ...  |  read more...
USD 350
Marina Biotech, Inc. (formerly MDRNA, Inc.) : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Marina Biotech, Inc. (formerly MDRNA, Inc.) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments ...  |  read more...
USD 350
Verenium Corporation (Formerly Diversa Corporation) : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Verenium Corporation (Formerly Diversa Corporation) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes ...  |  read more...
USD 350
Cytori Therapeutics, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Cytori Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Asuragen, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Asuragen, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
PolyTherics Limited : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' PolyTherics Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Life Technologies Corporation (formerly Invitrogen Corporation) : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Life Technologies Corporation (formerly Invitrogen Corporation) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments ...  |  read more...
USD 350
Senesco Technologies, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Senesco Technologies, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Sartorius Stedim Biotech S.A. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Sartorius Stedim Biotech S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, ...  |  read more...
USD 350
ImmunoGen, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' ImmunoGen, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
AmpliPhi Biosciences Corporation (formerly Targeted Genetics Corporation) : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' AmpliPhi Biosciences Corporation (formerly Targeted Genetics Corporation) Mergers & Acquisitions (M&A), Partnerships & Alliances ...  |  read more...
USD 350
Complete Genomics, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Complete Genomics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
RTI Biologics, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' RTI Biologics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Rosetta Genomics, Ltd. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Rosetta Genomics, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Albany Molecular Research, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Albany Molecular Research, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, ...  |  read more...
USD 350
The Latest Sales Figures in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... global pharmacuetical companies to progressive biotech companies. The analysis leverages the power of BioSeeker's 1stOncology intelligence which combines company disclosed product sales and detailed drug development information. The results is not only a unique insight ...  |  read more...
USD 4,478
Cesca Therapeutics Inc. (KOOL) - Financial and Strategic SWOT Analysis Review
7/15/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Advances in Enzyme Technology For the Food Industry
7/1/2014 | published by: Food Technology Intelligence
... developments such as these in the field of enzymology are emerging from research labs around the world. As you know, enzymes are used in foods and beverages to improve processing efficiency and the quality of ...  |  read more...
USD 360
Advanced Cell Diagnostics, Inc. - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... RNAscope assays, spotstudio software, instruments, accessory items and automated assays. ACD offers over 3,000 pre-designed single-plex target probes. The company offers services, such as start-up assay development service, biomarker validation, custom assay development and validation, ...  |  read more...
USD 750
DNA Vaccines: Technologies and Global Markets
7/1/2014 | published by: BCC Research
... by 2019, a compound annual growth rate (CAGR) of 54.8% over the five-year period from 2014 through 2019. This report provides: An overview of the global market for DNA vaccines and related technologies. Analyses of ...  |  read more...
USD 6,650
Blood-Brain Barrier Technologies and Global Markets
7/1/2014 | published by: BCC Research
... million in 2019, a compound annual growth rate (CAGR) of 64.9% from 2014 through 2019. This report provides: An overview of the global market for blood-brain barrier (BBB) therapeutics and technologies. Analyses of global market ...  |  read more...
USD 6,650
Life Sciences Research Tools Market (2014)
7/1/2014 | published by: DeciBio
... and (non-IVD) clinical customers. This market is consolidated, with top vendors including Agilent, Bio-Rad, EMD Millipore, Illumina, Life Technologies*, Roche, Sigma-Aldrich and Thermo Fisher representing the majority of sales; however, mid-size players (e.g., Luminex) and ...  |  read more...
USD 2,800
Creatine Kinase (CK): 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations France, Germany, Italy, Japan, Spain, UK, USA
6/16/2014 | published by: Venture Planning Group
... Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Laboratories POC/Decentralized Testing - Physician Offices/Group Practices - Ambulatory Care Centers - Emergency Departments - ICUs/CCUs List of ...  |  read more...
USD 750
Ark Therapeutics Group plc (AKT) - Financial and Strategic SWOT Analysis Review
7/2/2014 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
1  2  3    5    7  8  9  10